Results 81 to 90 of about 514,239 (249)
Diagnosis of a Gastrointestinal Stromal Tumor With Spontaneous Rupture
Gastrointestinal stromal tumors (GIST) are uncommon tumors accounting for 1% of gastrointestinal neoplasms. The most common location of GISTs is in the stomach. Commonly, these tumors present incidentally with an increased presence within older patients.
Silas, Dean +5 more
core +1 more source
Using peripheral blood for determining B‐cell or T‐cell clonality is more reliable when we use cell‐free RNA (cfRNA) because cells release blood significantly more RNA than DNA. Next‐generation sequencing (NGS) of cfRNA allows us to evaluate fragment cfRNA and evaluate clonality reliably without the need for prior determination of the specific dominant
Adam Albitar +11 more
wiley +1 more source
Gastrointestinal stromal tumors and concomitant neoplasms [PDF]
Gastrointestinalni stromalni tumori (GIST) najčešći su mezenhimalni tumori probavnoga trakta. Najčešće se javljaju sporadično. Unatoč tome, drugi primarni tumori kod bolesnika s GIST-om nisu rijetkost. Ovi se tumori mogu pojaviti u isto vrijeme (sinkrono)
Krstanac, Karolina
core +1 more source
The PAM pathway and its impact on cellular metabolism. Color‐coded key symbols represent Rapamycin (R, orange, targeting mTOR) and Dactolisib (D, green, targeting PI3K/mTOR), indicating their sites of action. Created with BioRenders.com. Glioblastoma resists therapy through interconnected survival programs.
Kai Zhao +23 more
wiley +1 more source
This prospective study demonstrates that laparoscopic sphincter‐preserving surgery is feasible for elderly patients. While overall survival reaches 70% at 5 years, advanced T‐stage and the omission of neoadjuvant therapy significantly drive recurrence, highlighting the need for personalized geriatric protocols despite logistical challenges.
Huu Duc Ho +4 more
wiley +1 more source
Gastrointestinal stromal tumor with chondroid differentiation
Gastrointestinal stromal tumors are mesenchymal neoplasms of the gastrointestinal tract that represent less than 1% of all GI tumors. Here the case of such a tumour that, in addition to the classical features, also displayed chondroid differentiation is ...
Villanacci V +7 more
core +1 more source
Cancer treatment is associated with measurable acceleration of biological aging across epigenetic, telomere, senescence, and immune biomarkers. However, biomarker validation and interventional strategies remain limited, especially in hematologic malignancies, underscoring the need for standardized multi‐omic aging assessments and adequately powered ...
Moataz Ellithi +3 more
wiley +1 more source
Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley +1 more source
UDC: 616.681-006:615.38:616-06 DOI: 10.2298/AOO0902025G
Testicular neoplasms metastasizing to the retroperitoneum rarely involve the upper gastrointestinal tract. We describe an unusual case of contained small bowel perforation as a complication of chemotherapy treatment of metastatic non seminomatous germ ...
Ehab Helmy +8 more
core
Paraneoplastic syndromes associated with tumors of the digestive system
Introduction: paraneoplastic syndromes are sets of signs and symptoms affecting cancer patients, which do not depend directly on the tumor. Objective: to describe paraneoplastic syndromes associated with digestive system tumors.
Roxana Vitón-Moreno +1 more
doaj

